COVID-19 UPDATES FOR PROVIDERS
Inpatient and Outpatient Preauthorization Update
As you know, New York State ordered a stop to elective surgeries and procedures due to the COVID-19 emergency (New York State Executive Order 202.10). We believe it is vital for members to have access to needed care, so we are reaching out to members and providers to help:
- For inpatient procedures, providers with open authorizations may receive a letter from us asking for them to contact us so we can work with them to extend the expiration date of the authorization, if needed.
- For outpatient services, EmblemHealth is extending the preauthorization date for affected members until Dec. 31, 2020. In this case, both members and their providers will receive letters with the information about their open authorizations.
For more COVID-19 updates, please visit our dedicated COVID-19 website.
July 1 Reminder: New IDs for GHI PPO City of NY
City of New York members with GHI PPO plans will move to our new claims platform on July 1. Members will be issued the same type of member ID numbers (the “K-ID”) as other GHI PPO members who migrated to the new system. The last two digits will distinguish the subscriber from each dependent, but the first set of digits will no longer be used as an identifier for NYC GHI PPO members. Click here to see changes that will apply once the new K-ID is in effect.
2020 Annual SNP MOC Training Launching Soon
CMS requires all Medicare providers complete annual Special Needs Plan (SNP) Model of Care (MOC) training. Providers in the VIP Prime Network must complete the 2020 EmblemHealth SNP MOC provider training by Sept. 30. Look for a notice to arrive via email, fax, and postal mail with the user ID and PIN number needed to access this online training. Providers who prefer to download the training and submit an attestation form confirming completion may do so here.
MEDICAID, HARP, AND CHPLUS (STATE-SPONSORED PROGRAMS) UPDATES
Medicaid: New York State Medicaid Update
To see the most recent updates from The Office of Health Insurance Programs of the New York State Department of Health, visit their website.
CLAIMS CORNERThe Claims Corner section of our website is a rich source of information that helps your practice navigate EmblemHealth claims and billing processes. Please check often to see posted updates.
Do Not Bill Dual Eligible Members for Any Medicare Balance DueIf Medicare-Medicaid dual eligible individuals have their Part A and Part B cost share covered by their Medicaid plan, they are not responsible for their Medicare Advantage cost share for covered services. Please do not balance bill these members for Medicare deductibles, coinsurance, or copayments. If you received Medicare and Medicaid payments for services given to these members, it must be accepted as payment in full.
Cytogenetic StudiesEmblemHealth has instituted a payment policy for cytogenetic studies, the microscopic examination of the physical appearance of human chromosomes as defined by CMS.
New Preauthorization Lookup ToolEmblemHealth has introduced a new and improved Preauthorization Checker for HIP and HIPIC members. Our new Preauthorization Checker does not require you to log in. You can find it pre-login in Clinical Corner where we house our preauthorization lists. To see it after you’ve logged in to the secure provider portal, select Prior Approval/Pre-Certification and the new tool will now be found in the left hand navigation bar. Information is subject to a member’s benefit plan and eligibility on the date of service.
Updated Clinical Practice Guidelines (CPGs)The following Clinical practice guidelines have been updated and are available on tour website.
Medical Policy UpdatesAll Medical Policies are available for download in Clinical Corner on our provider website. See updates to the following:
Medical Technologies DatabaseA comprehensive listing of medical technologies reviewed by the Medical Policy Committee for coverage consideration is available for download in Clinical Corner on our provider website.
PHARMACYEmblemHealth updates its Formulary on a regular basis. Find our most recent updates here.
EmblemHealth Introducing Biosimilar StrategyStarting July 1, 2020, EmblemHealth has selected preferred products for all lines of business for bevacizumab, trastuzumab, and rituximab. This does not apply to Group Health Incorporated (GHI) City of New York members.
Join us July 8 for our monthly webinarThe next session of our monthly webinar series will be held on Wednesday, July 8 from 10 a.m. to 11 a.m., and again from 2 p.m. to 3 p.m. Practitioners and office staff are welcome to join this monthly webinar that provides an overview of our products and benefit plans, special utilization management programs, and how to navigate our provider portal. Register today as space is limited.
Keep Your Directory Information CurrentIf a provider in your practice is leaving, please inform us as soon as possible. To report other changes, you can also sign into your Provider/Practice Profile on our secure website. If you participate with us under a delegated credentialing agreement, please have your administrator submit these changes.